Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
IMA	IMAGENEBIO INC	$31.01M	-24.90%	-22.50%	-25.78%	-34.00%	0.09	13.52	N/A	N/A	N/A
AZTA	AZENTA INC	$1.31B	-6.50%	-5.40%	-5.63%	-13.30%	0.21	2.76	44.90%	-18.40%	-16.50%
QIPT	QUIPT HOME MEDICAL CORP	$116.43M	-9.80%	-4.20%	-2.31%	-2.70%	1.30	1.15	18.10%	-4.50%	-1.78%
SLNO	SOLENO THERAPEUTICS INC	$3.45B	-73.70%	-56.70%	-57.20%	-67.90%	0.38	15.13	97.90%	-554.50%	-545.40%
ARDX	ARDELYX INC	$1.34B	-36.60%	-13.40%	-10.28%	-9.00%	2.35	4.30	84.80%	-14.60%	-10.25%
MNKD	MANNKIND CORP	$1.70B	-32.60%	7.80%	22.86%	11.40%	-8.48	2.50	74.90%	10.90%	22.71%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$2.80B	-245.10%	-37.70%	-52.36%	-32.40%	7.96	2.46	85.30%	-87.30%	-86.93%
LFMD	LIFEMD INC	$304.89M	N/A	-12.40%	-30.54%	19.90%	-41.06	0.77	87.60%	-3.70%	-1.25%
GERN	GERON CORP	$823.04M	-32.00%	-16.30%	-12.13%	-10.20%	1.14	7.87	97.80%	-53.50%	-36.21%
STOK	STOKE THERAPEUTICS INC	$1.32B	18.30%	15.50%	11.73%	30.70%	0.15	6.98	100.00%	26.30%	20.30%
RVTY	REVVITY INC	$9.76B	3.70%	2.30%	3.31%	8.00%	0.64	3.33	55.90%	10.20%	13.81%
LENZ	LENZ THERAPEUTICS INC	$1.20B	-25.60%	-24.40%	-25.08%	-29.60%	0.05	20.54	100.00%	-1,048.00%	-1,037.94%
OFIX	ORTHOFIX MEDICAL INC	$564.37M	-25.40%	-14.50%	-13.66%	-18.20%	0.83	2.67	67.40%	-15.30%	-11.63%
NAMS	NEWAMSTERDAM PHARMA CO NV	$3.21B	-24.60%	-22.60%	-21.28%	-324.10%	0.05	21.09	100.00%	-258.90%	-258.91%
GH	GUARDANT HEALTH INC	$7.49B	N/A	-29.00%	-37.46%	-23.00%	-5.36	3.71	62.80%	-49.90%	-49.43%
BFLY	BUTTERFLY NETWORK INC	$506.00M	-30.50%	-21.80%	-22.89%	-46.00%	0.35	5.68	62.00%	-71.80%	-70.25%
KZIA	KAZIA THERAPEUTICS LTD	$4.88M	N/A	-134.30%	-2,049.17%	330.20%	-0.85	0.21	100.00%	-1,134.80%	-1,145.67%
PGEN	PRECIGEN INC	$1.05B	-1,156.80%	-108.40%	-158.28%	-224.80%	-2.93	2.71	-0.70%	-2,868.70%	-2,870.25%
ALC	ALCON INC	$36.55B	4.90%	3.50%	5.01%	10.40%	0.42	2.60	55.10%	10.70%	14.47%
NSRX	NASUS PHARMA LTD	N/A	N/A	N/A	46.79%	N/A	-1.22	0.12	N/A	N/A	N/A
QNTM	QUANTUM BIOPHARMA LTD	$56.61M	-290.00%	-163.00%	-1,290.59%	-3,068.20%	3.52	0.78	N/A	N/A	N/A
TCRX	TSCAN THERAPEUTICS INC	$104.98M	-63.80%	-40.50%	-50.02%	-56.20%	0.69	7.06	100.00%	-1,964.90%	-1,920.20%
ACRS	ACLARIS THERAPEUTICS INC	$215.48M	-92.40%	-68.40%	-73.74%	-94.90%	0.38	5.06	14.90%	-732.40%	-732.42%
ANIK	ANIKA THERAPEUTICS INC	$130.05M	-38.50%	-29.80%	-33.47%	-40.90%	0.27	6.18	57.80%	-66.00%	-62.53%
MAZE	MAZE THERAPEUTICS INC	$1.18B	N/A	N/A	N/A	N/A	0.16	13.63	N/A	N/A	N/A
QURE	UNIQURE NV	$2.98B	-1,010.70%	-33.30%	-24.83%	-18.20%	-147.11	9.98	82.60%	-1,388.00%	-942.05%
CDTX	CIDARA THERAPEUTICS INC	$1.17B	-132.70%	-98.60%	-128.03%	831.10%	0.35	3.87	100.00%	-60,589.70%	-60,589.74%
EVO	EVOTEC SE	$1.24B	-16.90%	-8.10%	-8.51%	-8.40%	1.14	1.58	12.90%	-20.00%	-15.61%
SNDA	SONIDA SENIOR LIVING INC	$519.71M	-58.90%	-4.70%	0.66%	0.40%	12.98	0.85	22.10%	-11.10%	1.44%
MNPR	MONOPAR THERAPEUTICS	$472.80M	-41.80%	-39.50%	-33.11%	-198.40%	0.03	33.94	N/A	N/A	N/A
CTEV	CLARITEV CORP	$845.65M	-517.70%	-22.10%	-19.64%	-19.90%	341.97	1.02	74.10%	-127.00%	-103.84%
MGTX	MEIRAGTX HOLDINGS PLC	$658.06M	-315.60%	-63.50%	-99.57%	-76.00%	66.13	0.88	26.60%	-415.40%	-381.52%
VTGN	VISTAGEN THERAPEUTICS INC	$102.93M	-58.90%	-52.40%	-71.67%	-592.70%	0.20	6.51	100.00%	-10,579.80%	-10,578.40%
KROS	KEROS THERAPEUTICS INC	$651.88M	3.00%	2.70%	3.72%	61.90%	0.07	21.11	100.00%	8.10%	11.55%
TSHA	TAYSHA GENE THERAPIES INC	$886.58M	-79.90%	-45.70%	-30.08%	-175.00%	0.34	12.48	100.00%	-1,145.00%	-1,143.96%
OM	OUTSET MEDICAL INC	$257.33M	-145.40%	-38.40%	-34.42%	-25.50%	0.77	8.37	35.90%	-98.70%	-79.73%
SGRY	SURGERY PARTNERS INC	$2.80B	-10.10%	-2.30%	2.40%	3.10%	2.75	1.93	23.70%	-5.60%	5.46%
OMDA	OMADA HEALTH INC	N/A	N/A	N/A	N/A	N/A	-0.21	2.08	N/A	N/A	N/A
UTHR	UNITED THERAPEUTICS CORP	$19.57B	18.70%	16.50%	22.33%	31.40%	0.10	7.26	89.00%	40.40%	53.56%
MDXH	MDXHEALTH SA	$22.92M	-375.00%	-22.00%	-15.40%	-12.40%	-160.27	1.31	63.50%	-35.00%	-15.47%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$7.47B	-42.50%	-40.90%	-52.18%	-52.80%	0.03	41.92	N/A	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$1.29B	-106.30%	-87.90%	-108.80%	-160.80%	0.09	12.05	746.80%	17,205.70%	17,255.66%
CV	CAPSOVISION INC	$214.23M	N/A	N/A	N/A	N/A	-0.04	1.85	N/A	N/A	N/A
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$3.26B	-161.90%	-37.80%	-60.39%	-50.70%	3.56	1.54	90.90%	-296.80%	-277.82%
IMNM	IMMUNOME INC	$1.01B	-87.40%	-74.80%	-77.68%	-279.60%	0.10	12.13	100.00%	-1,687.10%	-1,687.08%
GALT	GALECTIN THERAPEUTICS INC	$291.47M	N/A	-226.00%	-694.90%	-50.60%	-1.12	1.43	N/A	N/A	N/A
PMI	PICARD MEDICAL INC	$641.20M	N/A	N/A	N/A	N/A	-0.84	0.21	N/A	N/A	N/A
CHE	CHEMED CORP	$6.74B	24.50%	16.90%	26.80%	65.30%	0.43	1.86	33.60%	11.60%	15.51%
ZLAB	ZAI LAB LTD	$3.43B	-33.30%	-23.30%	-29.14%	-151.50%	0.45	3.26	63.50%	-60.30%	-59.46%
SSII	SS INNOVATIONS INTERNATIONAL INC	$1.08B	-60.50%	-31.10%	-30.49%	-43.40%	0.67	2.59	49.20%	-66.20%	-61.11%
HRTX	HERON THERAPEUTICS INC	$184.60M	N/A	-3.40%	-3.60%	-1.80%	-9.29	2.40	74.00%	-5.20%	-3.57%
ALGS	ALIGOS THERAPEUTICS INC	$60.22M	-123.90%	-66.80%	-53.70%	-107.30%	0.32	6.31	100.00%	-2,337.20%	-1,936.36%
PVLA	PALVELLA THERAPEUTICS INC	$659.05M	-58.40%	-40.60%	-31.83%	371.60%	0.54	7.67	100.00%	50,203.80%	38,513.21%
SION	SIONNA THERAPEUTICS INC	$1.28B	N/A	N/A	N/A	N/A	0.05	35.33	N/A	N/A	N/A
RYTM	RHYTHM PHARMACEUTICALS INC	$6.59B	-1,884.80%	-49.70%	-66.25%	-95.90%	-20.08	2.79	89.20%	-120.50%	-103.12%
LCTX	LINEAGE CELL THERAPEUTICS INC	$390.49M	-60.20%	-39.70%	-51.11%	2,222.20%	0.90	4.08	97.60%	-374.80%	-374.84%
COSM	COSMOS HEALTH INC	$32.63M	-77.20%	-36.30%	-46.08%	-39.30%	1.36	0.98	9.80%	-39.10%	-25.65%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$13.58M	-237.50%	-189.30%	-285.68%	1,253.10%	0.31	4.26	N/A	N/A	N/A
NPCE	NEUROPACE INC	$337.43M	-168.60%	-25.50%	-19.51%	-12.40%	4.46	5.47	75.70%	-29.30%	-19.60%
IART	INTEGRA LIFESCIENCES HOLDINGS CORP	$1.03B	-35.60%	-12.70%	-17.55%	-18.30%	2.53	1.23	52.60%	-30.90%	-29.63%
TVRD	TVARDI THERAPEUTICS INC	$340.59M	-398.60%	-47.00%	-41.86%	-35.80%	0.33	4.04	100.00%	-317.50%	-210.40%
NRSN	NEUROSENSE THERAPEUTICS LTD	$30.51M	N/A	-491.20%	1,710.60%	441.30%	-4.25	0.71	N/A	N/A	N/A
XNCR	XENCOR INC	$825.21M	-25.70%	-18.40%	-17.20%	-13.80%	0.42	5.34	100.00%	-116.40%	-91.72%
CDXS	CODEXIS INC	$222.06M	-105.80%	-46.10%	-44.00%	-37.20%	1.49	5.82	77.60%	-113.70%	-94.68%
INSM	INSMED INC	$24.96B	-447.00%	-52.70%	-59.08%	-45.80%	17.18	5.86	76.50%	-265.90%	-242.45%
BBIO	BRIDGEBIO PHARMA INC	$9.57B	N/A	-87.60%	-70.83%	-29.80%	-1.60	5.19	96.20%	-329.30%	-271.62%
MLYS	MINERALYS THERAPEUTICS INC	$2.65B	-70.40%	-65.50%	-60.84%	-126.10%	0.07	15.12	N/A	N/A	N/A
HTFL	HEARTFLOW INC	$2.76B	N/A	N/A	N/A	N/A	-0.32	3.60	N/A	N/A	N/A
NRC	NATIONAL RESEARCH CORP	$303.05M	71.30%	18.70%	36.04%	47.00%	3.56	0.54	60.30%	17.10%	24.85%
RNAC	CARTESIAN THERAPEUTICS INC	$240.34M	N/A	-10.30%	-9.65%	-20.90%	-19.78	12.34	100.00%	-124.40%	-111.27%
ORGO	ORGANOGENESIS HOLDINGS INC	$520.10M	-7.80%	-4.40%	-6.01%	-7.70%	0.41	4.12	75.90%	-4.50%	-5.27%
PASG	PASSAGE BIO INC	$25.43M	-103.90%	-59.90%	-95.72%	-105.40%	1.07	3.05	N/A	N/A	N/A
MOH	MOLINA HEALTHCARE INC	$10.41B	24.90%	7.10%	19.84%	37.30%	2.52	1.67	10.90%	2.60%	3.81%
ALMS	ALUMIS INC	$421.46M	-72.10%	-56.00%	-44.94%	-116.10%	0.26	6.05	100.00%	-1,134.50%	-1,177.16%
INSP	INSPIRE MEDICAL SYSTEMS INC	$2.28B	7.90%	6.80%	8.30%	9.50%	0.18	6.14	84.50%	6.20%	6.83%
RLAY	RELAY THERAPEUTICS INC	$886.37M	-44.20%	-39.50%	-43.73%	-46.50%	0.11	19.96	100.00%	-4,341.50%	-4,341.53%
LBRX	LB PHARMACEUTICALS INC	N/A	N/A	N/A	N/A	N/A	-0.09	3.78	N/A	N/A	N/A
BLFS	BIOLIFE SOLUTIONS INC	$1.17B	-3.10%	-2.70%	-2.91%	-10.10%	0.12	4.73	69.60%	-13.10%	-13.46%
UNH	UNITEDHEALTH GROUP INC	$311.62B	22.60%	7.00%	15.12%	25.80%	2.15	0.85	20.80%	5.00%	7.07%
STRO	SUTRO BIOPHARMA INC	$74.92M	-347.60%	-59.50%	-116.00%	-133.70%	-13.45	2.16	100.00%	-369.10%	-328.94%
ACIU	AC IMMUNE SA	$285.17M	-49.00%	-23.10%	-55.17%	-112.50%	1.55	1.33	100.00%	-174.70%	-174.09%
LNTH	LANTHEUS HOLDINGS INC	$3.44B	23.60%	13.20%	21.57%	36.90%	0.81	4.29	63.70%	17.80%	26.04%
PTGX	PROTAGONIST THERAPEUTICS INC	$4.19B	8.10%	7.40%	7.88%	10.00%	0.08	16.97	100.00%	24.90%	25.71%
GRAL	GRAIL INC	$1.80B	-18.00%	-15.20%	-22.75%	-104.70%	0.17	9.23	-56.50%	-329.90%	-445.82%
LEGN	LEGEND BIOTECH CORP	$6.16B	-30.90%	-19.40%	-19.89%	-40.60%	0.63	4.71	62.50%	-40.80%	-35.56%
ARVN	ARVINAS INC	$607.16M	-12.00%	-7.00%	-9.65%	-9.90%	0.49	5.64	100.00%	-19.50%	-19.45%
CNC	CENTENE CORP	$17.12B	7.50%	2.40%	6.96%	11.70%	2.15	1.10	8.90%	1.20%	1.94%
PRCT	PROCEPT BIOROBOTICS CORP	$2.04B	-23.70%	-17.30%	-17.32%	-35.60%	0.33	9.21	64.20%	-30.60%	-29.19%
STTK	SHATTUCK LABS INC	$109.22M	-81.80%	-71.50%	-104.20%	-229.30%	0.13	10.25	100.00%	-2,052.50%	-2,052.52%
PROK	PROKIDNEY CORP	$732.76M	N/A	-17.10%	-20.84%	-23.90%	-0.03	11.48	100.00%	-13,752.20%	-13,599.62%
NVAX	NOVAVAX INC	$1.39B	-142.30%	28.70%	47.97%	117.00%	34.52	2.36	88.30%	39.20%	42.13%
GHRS	GH RESEARCH PLC	$895.69M	-16.70%	-16.10%	-13.28%	-54.40%	0.03	29.49	N/A	N/A	N/A
ARAY	ACCURAY INC	$188.17M	-2.80%	-0.30%	5.07%	4.00%	4.79	1.65	32.10%	-0.30%	3.07%
ANIX	ANIXA BIOSCIENCES INC	$111.92M	-63.10%	-59.20%	-71.32%	-71.90%	0.14	8.45	N/A	N/A	N/A
ICLR	ICON PLC	$12.74B	8.30%	4.70%	7.27%	22.40%	0.74	1.29	28.60%	9.80%	12.61%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$602.02M	-24.90%	-17.80%	-28.76%	-206.10%	0.34	5.90	100.00%	-49.30%	-61.89%
ATAI	ATAI LIFE SCIENCES NV	$1.13B	-85.60%	-64.40%	-71.26%	-83.40%	0.32	4.02	100.00%	-5,171.20%	-5,050.97%
GLUE	MONTE ROSA THERAPEUTICS INC	$460.71M	2.70%	1.70%	2.83%	4.70%	0.43	5.61	100.00%	3.90%	5.93%
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$84.36M	-201.50%	-95.30%	-130.90%	-179.20%	0.84	0.83	65.70%	-3,934.40%	-3,832.35%
ABCL	ABCELLERA BIOLOGICS INC	$1.41B	-15.70%	-12.20%	-16.60%	-19.30%	0.31	10.15	100.00%	-726.20%	-911.24%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	634	+1.79%	+1.91%	+6.43%	-34.10%	-103.63x	4.74x	-110.35%	-7.14%	-11.38%	+74.80%	Strong Buy
Diagnostics & Research	56	+1.01%	-2.91%	-2.11%	-20.34%	20.19x	3.68x	-3.05%	+7.21%	+15.74%	+12.47%	Strong Buy
Drug Manufacturers - General	19	+1.12%	-2.43%	-1.22%	-11.24%	36.82x	5.90x	+60.33%	+10.39%	+17.87%	+44.86%	Buy
Drug Manufacturers - Specialty & Generic	76	+0.80%	-1.60%	+0.72%	-14.92%	-26.18x	2.19x	+11.47%	+4.52%	+9.99%	+34.64%	Buy
Healthcare Plans	11	+0.51%	+2.09%	+1.67%	-31.43%	14.69x	2.04x	+15.83%	+4.97%	+11.53%	+16.07%	Buy
Health Information Services	53	+1.70%	-0.25%	-0.80%	-51.95%	79.61x	4.19x	+8.45%	+5.32%	+9.21%	+27.22%	Strong Buy
Medical Care Facilities	47	+1.83%	+4.11%	+3.99%	-27.10%	16.54x	5.02x	-187.08%	+6.89%	+15.30%	+13.48%	Buy
Medical Devices	142	+0.34%	-2.25%	-5.08%	-29.83%	30.11x	3.93x	+13.92%	+8.58%	+10.09%	+31.97%	Strong Buy
Medical Distribution	10	+2.95%	+6.64%	+8.45%	+42.42%	28.76x	311.71x	-10.64%	+3.09%	+19.03%	+11.15%	Buy
Medical Instruments & Supplies	55	+1.38%	-1.61%	-4.20%	-63.95%	29.83x	3.29x	+10.52%	+8.43%	+11.16%	+28.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: B.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 74.57% over the past year, overperforming other healthcare stocks by 108 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 82.42% from Theravance Biopharma's current stock price of $14.07.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -4.34% over the past year, overperforming other healthcare stocks by 29 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 33.09% from Embecta's current stock price of $13.90.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #3 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 29, which is 4 points higher than the healthcare sector average of 25. It passed 9 out of 33 due diligence checks and has average fundamentals. Infusystem Holdings has seen its stock return 57.62% over the past year, overperforming other healthcare stocks by 91 percentage points.

Infusystem Holdings has an average 1 year price target of $13.50, an upside of 30.56% from Infusystem Holdings's current stock price of $10.34.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.55%, which is 12 percentage points higher than the healthcare sector average of 2.08%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 8.33%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Cryo Cell International's dividend payout ratio of -2,166.7% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.89%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 1.36% in the last day, and up 0.15% over the last week. Bioaffinity Technologies was the among the top gainers in the healthcare sector, gaining 55.13% yesterday.

bioAffinity Technologies shares are trading lower after the company priced a $4.8M public offering of ~1.92M shares or pre-funded warrants at $2.50 per share.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -30.86% in the past year. It has overperformed other stocks in the healthcare sector by 2 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -4.34% in the past year. It has overperformed other stocks in the healthcare sector by 29 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 89.06% in the past year. It has overperformed other stocks in the healthcare sector by 122 percentage points.

Are healthcare stocks a good buy now?

52.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.4% over the next year.

5.3% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.13% of healthcare stocks are rated B (Buy), 46.64% are rated C (Hold), 24.62% are rated D (Sell), and 11.31% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.